MicroPort CardioFlow Medtech (72X) Stock Overview
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
72X Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
MicroPort CardioFlow Medtech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.12 |
| 52 Week High | HK$0.17 |
| 52 Week Low | HK$0.041 |
| Beta | 0.44 |
| 1 Month Change | -7.69% |
| 3 Month Change | -24.53% |
| 1 Year Change | 166.67% |
| 3 Year Change | -60.26% |
| 5 Year Change | n/a |
| Change since IPO | -93.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 72X | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.6% | -5.1% | -3.3% |
| 1Y | 166.7% | -14.9% | 10.6% |
Return vs Industry: 72X exceeded the German Medical Equipment industry which returned -14.7% over the past year.
Return vs Market: 72X exceeded the German Market which returned 12% over the past year.
Price Volatility
| 72X volatility | |
|---|---|
| 72X Average Weekly Movement | 7.6% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 72X's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 72X's weekly volatility has decreased from 35% to 8% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 417 | Ruinian Zhang | www.cardioflowmedtech.com |
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, transcatheter mitral valves, transcatheter tricuspid valves, and surgical accessories, as well as procedural accessories; and VitaFlow, VitaFlow Liberty, VitaFlow Liberty Flex, Alwide Plus, AccuSniperTM, AnchorMan LAAC System, AnchorMan LAAA System, and various TAVI, TMV, TTV, and LAA products.
MicroPort CardioFlow Medtech Corporation Fundamentals Summary
| 72X fundamental statistics | |
|---|---|
| Market cap | €302.45m |
| Earnings (TTM) | €589.51k |
| Revenue (TTM) | €44.65m |
Is 72X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 72X income statement (TTM) | |
|---|---|
| Revenue | CN¥367.53m |
| Cost of Revenue | CN¥113.62m |
| Gross Profit | CN¥253.91m |
| Other Expenses | CN¥249.06m |
| Earnings | CN¥4.85m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.002 |
| Gross Margin | 69.09% |
| Net Profit Margin | 1.32% |
| Debt/Equity Ratio | 11.5% |
How did 72X perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/18 12:27 |
| End of Day Share Price | 2025/11/18 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MicroPort CardioFlow Medtech Corporation is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harry He | CGS International |
| Bo Yu | China International Capital Corporation Limited |
| Yuan Gao | China International Capital Corporation Limited |